Department of Cardiology, Vejle Sygehus, Kabbeltoft 25, DK-7100 Vejle, Denmark.
J Cardiovasc Comput Tomogr. 2009 Nov-Dec;3(6):386-91. doi: 10.1016/j.jcct.2009.10.006. Epub 2009 Oct 30.
The optimal method of determining the pretest risk of coronary artery disease as a patient selection tool before coronary multidetector computed tomography (MDCT) is unknown.
We investigated the ability of 3 different clinical risk scores to predict the outcome of coronary MDCT.
This was a retrospective study of 551 patients consecutively referred for coronary MDCT on a suspicion of coronary artery disease. Diamond-Forrester, Duke, and Morise risk models were used to predict coronary artery stenosis (>50%) as assessed by coronary MDCT. The models were compared by receiver operating characteristic analysis. The distribution of low-, intermediate-, and high-risk persons, respectively, was established and compared for each of the 3 risk models.
Overall, all risk prediction models performed equally well. However, the Duke risk model classified the low-risk patients more correctly than did the other models (P < 0.01). In patients without coronary artery calcification (CAC), the predictive value of the Duke risk model was superior to the other risk models (P < 0.05). Currently available risk prediction models seem to perform better in patients without CAC. Between the risk prediction models, there was a significant discrepancy in the distribution of patients at low, intermediate, or high risk (P < 0.01).
The 3 risk prediction models perform equally well, although the Duke risk score may have advantages in subsets of patients. The choice of risk prediction model affects the referral pattern to MDCT.
作为冠状动脉多排 CT(MDCT)检查前的患者选择工具,确定冠状动脉疾病术前风险的最佳方法尚不清楚。
我们旨在研究 3 种不同的临床风险评分对预测冠状动脉 MDCT 结果的能力。
这是一项回顾性研究,连续纳入了 551 例疑诊冠状动脉疾病而行冠状动脉 MDCT 检查的患者。采用 Diamond-Forrester、Duke 和 Morise 风险模型预测冠状动脉 MDCT 评估的冠状动脉狭窄(>50%)。通过接受者操作特征分析比较模型。分别为 3 种风险模型建立低、中、高危人群的分布,并进行比较。
总体而言,所有风险预测模型的性能相当。然而,Duke 风险模型对低危患者的分类比其他模型更准确(P < 0.01)。在无冠状动脉钙化(CAC)的患者中,Duke 风险模型的预测价值优于其他风险模型(P < 0.05)。目前可用的风险预测模型在无 CAC 的患者中似乎表现更好。在风险预测模型之间,低、中、高危患者的分布存在显著差异(P < 0.01)。
3 种风险预测模型的性能相当,尽管 Duke 风险评分在某些患者亚组中可能具有优势。风险预测模型的选择会影响 MDCT 的转诊模式。